Tuagon, Mark Jade P.
HRN: 19-96-54 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CEFUROXIME 1.5GM (VIAL)
01/16/2023
01/23/2023
IVTT
360mg
Q8
BFC; PCAP C
Waiting Final Action
01/19/2023
CEFTRIAXONE 1G (VIAL)
01/19/2023
01/26/2023
IV
1 G
Q24
PCAP C
Waiting Final Action